Literature DB >> 700894

Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.

E L Wilson, E Dowdle.   

Abstract

Plasminogen activator secretion by 39 primary or early-passage cultures of malignant human neoplasms has been compared with that of 16 similar cultures of benign neoplasms and 39 cultures of normal or reactive tissue. While normal cells of mesenchymal or neural origin secreted considerably less plasminogen activator than did cells from frankly malignant tissues, elevated levels of enzyme secretion were also encountered in cultures of benign neoplastic or reactive cells. In the case of epithelial tissue, no consistent relationship between plasminogen activator secretion and neoplasia could be documented. Our failure to observe, for any particular cell type, a reproducible correlation between malignancy and plasminogen activator secretion may be attributable to the artificial conditions of in vitro culture, where normal in vivo regulatory mechanisms do not obtain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 700894     DOI: 10.1002/ijc.2910220405

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Characterization of an inhibitor of cell division released in tumour cell cultures.

Authors:  J Werkmeister; J Zaunders; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

Review 2.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

4.  Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.

Authors:  L Ossowski; D Belin
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

5.  Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

Review 6.  Extracellular matrix destruction by invasive tumor cells.

Authors:  P A Jones; Y A De Clerck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Tumor production in the nude mouse, fibrinolytic activity and cross-reactivity with antimelanoma sera of various human tumor cell lines.

Authors:  J Brüggen; J Fogh; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

8.  Binding of Lys-plasminogen to monocytes/macrophages.

Authors:  R L Silverstein; R J Friedlander; R L Nicholas; R L Nachman
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells.

Authors:  E L Wilson; G E Francis
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.

Authors:  L Skriver; L I Larsson; V Kielberg; L S Nielsen; P B Andresen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.